Epidemiology and Risk Factors of Osteosarcoma

Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study

(2019) Xiaoyi Huang et al.   Journal of Bone Oncology

Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients

(2018) Gehad Ahmed et al.   JOURNAL OF PEDIATRIC SURGERY

Fluoride-Induced Oxidative and Inflammatory Stress in Osteosarcoma Cells: Does It Affect Bone Development Pathway?

(2016) Deepa Gandhi et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

(2016) N. J. Mason et al.   CLINICAL CANCER RESEARCH

Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

(2016) Carolina Zandueta et al.   JOURNAL OF PATHOLOGY

The pharmacogenomics of osteosarcoma

(2016) M Serra et al.   PHARMACOGENOMICS JOURNAL

miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma

(2016) Shuguang Zhou et al.   TUMOR BIOLOGY

Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells

(2016) Jir-You Wang et al.   Stem Cells Translational Medicine

Editorial: Thoracolumbar Spinal Injuries

(2016) Charoen Chotigavanich   Journal of Orthopaedic Surgery

High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma

(2015) C R Hong et al.   BONE MARROW TRANSPLANTATION

Modeling Familial Cancer with Induced Pluripotent Stem Cells

(2015) Dung-Fang Lee et al.   CELL

FBXW7 Acts as an Independent Prognostic Marker and Inhibits Tumor Growth in Human Osteosarcoma

(2015) Zhanchun Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies

(2015) Timo Gemoll et al.   Oncotarget

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review

(2014) N C Daw et al.   BRITISH JOURNAL OF CANCER

Notch Activation as a Driver of Osteogenic Sarcoma

(2014) Jianning Tao et al.   CANCER CELL

Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma

(2014) Xiang Chen et al.   Cell Reports

Genome-wide association study identifies two susceptibility loci for osteosarcoma

(2013) Sharon A Savage et al.   NATURE GENETICS

Height at diagnosis and birth-weight as risk factors for osteosarcoma

(2011) Lisa Mirabello et al.   CANCER CAUSES & CONTROL

Modeling sarcomagenesis using multipotent mesenchymal stem cells

(2011) Rene Rodriguez et al.   CELL RESEARCH

Notch Signaling Pathway Enhances Bone Morphogenetic Protein 2 (BMP2) Responsiveness of Msx2 Gene to Induce Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells

(2011) Takehisa Shimizu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002

(2010) Rachel Eyre et al.   BMC CANCER

Osteosarcoma – conventional treatment vs. gene therapy

(2010) Mei Lin Tan et al.   CANCER BIOLOGY & THERAPY

Fifty years of cancer incidence: CI5 I-IX

(2010) D. Max Parkin et al.   INTERNATIONAL JOURNAL OF CANCER

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Osteosarcoma treatment: state of the art

(2009) Hang T. Ta et al.   CANCER AND METASTASIS REVIEWS

International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

(2009) Lisa Mirabello et al.   INTERNATIONAL JOURNAL OF CANCER

Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss ofCdkn2

(2009) Alexander B Mohseny et al.   JOURNAL OF PATHOLOGY

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

(2009) V. Subbiah et al.   OSTEOPOROSIS INTERNATIONAL

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease

(2008) C. R. Walkley et al.   GENES & DEVELOPMENT

Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage

(2008) S. D. Berman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Paget’s disease of bone: a review

(2008) Matteo Colina et al.   RHEUMATOLOGY INTERNATIONAL

Trends in childhood cancer incidence in the U.S. (1992–2004)

(2007) Amy M. Linabery et al.   CANCER